Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wittekindt

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
HNO|February 12, 2016
[Human papillomavirus and squamous cell cancer of the head and neck region : Prognostic, therapeutic and prophylactic implications]M Reuschenbach, S Wagner, N Würdemann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2017
A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)J Inhestern, H Schmalenberg, A Dietz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinomaJ H Rasmussen, C Grønhøj, K Håkansson, et al.
Laryngo- Rhino- Otologie|August 10, 2013
[The new S2k AWMF guideline for the treatment of obstructive sialadenitis in commented short form]B Al-Nawas, D Beutner, U Geisthoff, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 16, 2014
Updated S2K AWMF guideline for the diagnosis and follow-up of obstructive sialadenitis--relevance for radiologic imagingT J Vogl, B Al-Nawas, D Beutner, et al.
HNO|October 29, 2015
[HPV-associated head and neck cancer : mutational signature and genomic aberrations]S Wagner, N Würdemann, C Hübbers, et al.
HNO|March 9, 2004
[HPV-associated tonsillar cancer. An update]J P Klussmann, S Dinh, O Guntinas-Lichius, et al.
British Journal of Cancer|January 24, 2008
Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancerS F Preuss, A Weinell, M Molitor, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy eraA Alberti, C Gurizzan, C Resteghini, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
HNO|February 12, 2016
[Human papillomavirus and squamous cell cancer of the head and neck region : Prognostic, therapeutic and prophylactic implications]M Reuschenbach, S Wagner, N Würdemann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2017
A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)J Inhestern, H Schmalenberg, A Dietz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinomaJ H Rasmussen, C Grønhøj, K Håkansson, et al.
Laryngo- Rhino- Otologie|August 10, 2013
[The new S2k AWMF guideline for the treatment of obstructive sialadenitis in commented short form]B Al-Nawas, D Beutner, U Geisthoff, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 16, 2014
Updated S2K AWMF guideline for the diagnosis and follow-up of obstructive sialadenitis--relevance for radiologic imagingT J Vogl, B Al-Nawas, D Beutner, et al.
HNO|October 29, 2015
[HPV-associated head and neck cancer : mutational signature and genomic aberrations]S Wagner, N Würdemann, C Hübbers, et al.
HNO|March 9, 2004
[HPV-associated tonsillar cancer. An update]J P Klussmann, S Dinh, O Guntinas-Lichius, et al.
British Journal of Cancer|January 24, 2008
Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancerS F Preuss, A Weinell, M Molitor, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy eraA Alberti, C Gurizzan, C Resteghini, et al.
Pageof 5